The objective of the 2013 realignment was to unify and optimize the Company’s operating structure. The realignment combined various functions within the organization such as operations, sales and marketing, research & development, finance and HR, which now serve the entire Company. Each functional area (i.e. Global Sales & Marketing, Global Operations) is managed by one executive that reports to our President and Chief Executive Officer (“CEO”). A current organization chart of those executives directly reporting to the CEO is included below for your reference.
Rest of the answer
Additionally, please see our Current Report on Form 8-K filed with the Securities and Exchange Commission on June 5, 2013 for further description of our 2013 operating structure realignment.
President & CEO
SVP & Chief Technology Officer
EVP, Global Operations
EVP Global Sales & Marketing
EVP & Chief Financial Officer
SVP Human Resources
SVP & General Counsel
As defined in ASC 280-10-50-1 – Segment Reporting, an operating segment is a component of a public company that has all the following characteristics: a) It engages in business activities from which it may earn revenues and incur expenses; b) Operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance; c) Discrete financial information is available. We evaluated the above criteria in connection with our realignment of the Company’s operating structure and concluded that only two operating and reportable segments exist - Greatbatch Medical and QiG. This was determined based upon the following:
•
In accordance with ASC 280-10-50-5, the function of the CODM is to allocate resources to and assess the performance of the segments of a public entity. Based upon this definition, the Company determined that its CEO is the CODM as he has the final decision making authority over how resources are allocated. It should be noted that, other than the CEO, there is no group or individual executive (i.e. executive team) within the Company that is responsible for making decisions over resource allocation for the Company as a whole. Each executive reporting to the CEO only has decision making authority related to their specific function within the Company (i.e. Global Sales & Marketing, Global Operations).
Commencing in the fourth quarter of 2013, the CODM of Greatbatch began regularly reviewing discrete financial information for Greatbatch Medical, QiG and Corporate Support (i.e. Finance, HR, Legal). For this analysis, the Corporate Support function was determined not to be an operating segment as it does not earn revenue (i.e. it only incurs expenses). This is consistent with ASC 280-10-50-4. Greatbatch Medical and QiG were both determined to be operating segments as they meet all three criteria of ASC 280-10-50-1. It should be noted that per ASC 280-10-50-3 an operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. This guidance was considered in determining that QiG is an operating segment.
It should be noted that there are multiple product lines within the Greatbatch Medical segment, which the Company has considered in determining its operating segments. Since discrete financial information is not regularly reviewed by the CODM for these product lines (i.e. only revenue information is reviewed) these were not considered operating segments. Note that, as discussed further below, our CEO is also considered the segment manager for both Greatbatch Medical and QiG.
Based upon our analysis, we determined that Greatbatch Medical and QiG do not meet the criteria of ASC 280-10-50-11 for aggregation. Thus, Greatbatch Medical and QiG were determined to be our reportable segments as defined in ASC 280-10-50-10.
In accordance with ASC 350-20-35-1, goodwill shall be tested for impairment at a level of reporting referred to as a reporting unit. A reporting unit is defined as an operating segment or one level below an operating segment (also known as a component). Per ASC 350-20-35-34, a component of an operating segment is a reporting unit if the component constitutes a business or nonprofit activity for which discrete financial information is available and segment management, as the term defined in ASC 280-10-50-7, regularly reviews the operating results of that component. ASC 280-10-50-7 defines a segment manager as an individual who is directly accountable to and maintains regular contact with the chief operating decision maker to discuss operating activities, financial results, forecasts, or plans for the segment.
As a result of the 2013 operating structure realignment, the only person who is responsible for the Company’s operating segments (GB Medical and QiG) in their entirety is the CEO who is also the CODM. Each executive who maintains regular contact with the CEO only has decision making authority and is only directly responsible for their specific function within the Company (i.e. Global Sales & Marketing, Global Operations). There is not one executive or team that has sole responsibility for allocating all resources for either Greatbatch Medical or QiG other than the CEO who manages each of these operating segments as a whole. We note that this determination is consistent with ASC 280-10-50-8, which specifically states that the CODM may also be the segment manager for certain operating segments. It is also important to note that the compensation for each executive reporting directly to the CEO is based upon the consolidated financial results of the Company.
As discussed above, the CODM of Greatbatch, who is also the segment manager for Greatbatch Medical and QiG, regularly reviews discrete financial information for Greatbatch Medical, QiG and Corporate Support (i.e. Finance, HR, Legal) only. Consistent with our operating segment analysis, the Corporate Support function is not deemed to be a business for purposes of determining the Company’s components. Accordingly, the Company has determined that there are no components for its Greatbatch Medical and QiG operating segments and that its operating segments are also the reporting units which should be tested for impairment of goodwill.